About Index Trending news
Lists
Pricing
MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx Pharmaceuticals, Inc.

MicuRx is a clinicalstage biopharmaceutical company developing innovative antibiotics for multidrugresistant (MDR) bacterial infections including MRSA and VRE..

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$55,000,000
GP Healthcare Capital, GP TMT Capital, 3E Bioventures Capital, +3
Venture capital (Series B)
$25,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$55,000,000 Venture capital (Series C)
yahoo , FinSMEs , prnasia

MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I

Health